U.S. flag

An official website of the United States government

Filters

reset all
See more specimen types...
See more states

Other countries

Results: 1 to 20 of 60

Tests names and labsConditionsGenes, analytes, and microbesMethods

Guardant360 TissueNext

Guardant Health
United States
187
  • M Methylation analysis
  • I Microsatellite instability testing (MSI)
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Guardant360 Response

Guardant Health
United States
174
  • E Sequence analysis of select exons
  • T Targeted variant analysis

NeXT Dx

Personalis, Inc.
United States
1269
  • I Microsatellite instability testing (MSI)
  • R RNA analysis
  • C Sequence analysis of the entire coding region

FoundationOne®

Foundation Medicine, Inc.
United States
12
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Guardant360

Guardant Health
United States
185
  • I Microsatellite instability testing (MSI)
  • E Sequence analysis of select exons
  • T Targeted variant analysis

OnkoRisk Hereditary Oncology Plus Panel

BioReference Health
United States
9777
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Oncology Management Panel

BioReference Health
United States
4717
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Oncology Guideline Panel

BioReference Health
United States
7154
  • C Sequence analysis of the entire coding region

OnkoRisk Women's Hereditary Cancer Panel

BioReference Health
United States
3418
  • C Sequence analysis of the entire coding region

FoundationOne CDx

Foundation Medicine, Inc.
United States
11
  • D Deletion/duplication analysis
  • I Microsatellite instability testing (MSI)
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

KRAS Mutation Analysis

PathGroup
United States
131
  • T Targeted variant analysis

Tempus xT

Tempus Labs, Inc.
United States
2647
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

HopeSeq Solid Tumors

Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center
United States
13
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons

Tempus xR

Tempus Labs, Inc.
United States
23
  • R RNA analysis

OncoExTra

Exact Sciences Precision Oncology Laboratory, Phoenix
United States
12
  • S Mutation scanning of the entire coding region
  • R RNA analysis

BRAF V600 Somatic Mutation Analysis, Tumor

Mayo Clinic Laboratories Mayo Clinic
United States
11
  • T Targeted variant analysis

Neuro-Onc Expanded Panel

Mayo Clinic Laboratories Mayo Clinic
United States
1118
  • E Sequence analysis of select exons

Solid Tumor Fusion Analysis

Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital
United States
1115
  • R RNA analysis

Cytogenomic Molecular Inversion Probe Array FFPE Tissue - Oncology

ARUP Laboratories, Cytogenetics and Genomic Microarray ARUP Laboratories
United States
51
  • K Karyotyping

MayoComplete Solid Tumor Panel

Mayo Clinic Laboratories Mayo Clinic
United States
1476
  • I Microsatellite instability testing (MSI)
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 60

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.